About Aseptix
Aseptix was founded in 2005 as a manufacturer in the antimicrobial products sector. Operations center on the development and production of solutions designed to inhibit microbial growth in healthcare, consumer, and industrial applications. Research efforts are directed toward creating effective formulations, with distribution facilitated through the companys online domain. Focus remains on standard compliance and product efficacy across global markets.
- Headquarter Loenen Aan De Vecht, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aseptix
Detailed funding history for Aseptix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aseptix
Aseptix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ecolab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-enabled water-efficient products are supplied for global industries.
|
Locked | Locked | Locked |
Investor details for Aseptix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aseptix
Investment portfolio details for Aseptix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aseptix
Detailed financials for Aseptix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aseptix Comparisons
Peer comparison for Aseptix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aseptix
Detailed competitors of Aseptix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aseptix
Complete news archive for Aseptix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aseptix
Aseptix was founded in 2005.
Aseptix is headquartered in Loenen Aan De Vecht, Netherlands. It is registered at Loenen Aan De Vecht, Utrecht, Netherlands.
Aseptix was founded in 2005 as a manufacturer in the antimicrobial products sector. Operations center on the development and production of solutions designed to inhibit microbial growth in healthcare, consumer, and industrial applications. Research efforts are directed toward creating effective formulations, with distribution facilitated through the companys online domain. Focus remains on standard compliance and product efficacy across global markets.
Aseptix has 1 investor. Key investors include Ecolab.